Wegovy tablets have now been approved by the MHRA in the UK. However, they are not yet available to buy, as stock is expected to take a short time to reach UK pharmacies.
Chemist Click will offer Wegovy tablets soon through a regulated online consultation, subject to clinical suitability and prescription approval. You can join our list to be notified as soon as Wegovy tablets become available to order.
| Name & Dosage | x30 Tablets |
|---|---|
| Wegovy 1.5mg Tablets | £98.99 |
| Wegovy 4mg Tablets | £104.99 |
| Wegovy 9mg Tablets | £118.99 |
| Wegovy 25mg Tablets | £197.99 |
| Medication Class | GLP-1 receptor agonist |
|---|---|
| Active ingredient | Semaglutide |
| How Wegovy tablets work | Reduces appetite Increases feeling of fullness Slows the rate at which food leaves the stomach |
| How to take Wegovy tablets | Take one tablet daily in the morning on an empty stomach. Wait 30 minutes before eating, drinking, or taking any other medication. Do not split, chew or crush Wegovy tablets. |
| Effective within | 1-2 weeks: Appetite reduction 4-8 weeks: Noticeable weight loss 3-6 months onwards: Peak clinical effect |
| Weight loss potential | Clinical trial data showed average weight loss of around 13.6% to 16.6%, depending on treatment adherence |
| UK availability | Yes, subject to stock arriving in the UK |
| Are they the same as Wegovy injections? | They contain the same active ingredient, semaglutide, but are taken daily by mouth instead of once weekly by injection. |
| Do they need a prescription? | Yes. A prescription will only be issued after a clinical assessment. |
Wegovy tablets are an oral form of semaglutide designed to support weight loss. They contain the same active ingredient as Wegovy injections, but are taken by mouth instead of injected.
They are taken once daily and work by reducing appetite, increasing feelings of fullness and helping you eat fewer calories over time.
This makes them a potential needle-free alternative for people who want the benefits of semaglutide weight loss treatment without using injections.
Wegovy tablets contain semaglutide, a GLP-1 receptor agonist.
They work by:
An oral (tablet) form delivers semaglutide through the digestive system using absorption-enhancing technology so that enough medication enters the bloodstream to produce the same appetite-regulating effects as weight loss injections.
Key findings from late-stage studies (e.g., OASIS trials):

Source: Wharton S, et al. N Engl J Med 2025;393:1077–1087
Further reading: Wegovy tablets results
Wegovy tablets contain oral semaglutide, the same active ingredient as Wegovy injections. Clinical trials suggest they have a safety profile broadly similar to injectable Wegovy, with the most common side effects being nausea, vomiting, constipation and diarrhoea.
Most digestive side effects were mild to moderate and improved over time, but Wegovy tablets are not suitable for everyone and should only be used after a clinical assessment.
| Feature | Wegovy Injections | Wegovy Tablets (Oral Semaglutide) |
|---|---|---|
| Form | Once-weekly injection | Daily tablet |
| Availability | Approved and available in the UK | Approved in the UK. Available shortly. |
| Effectiveness | Around 15% average weight loss with standard 2.4mg dosing; higher-dose Wegovy injections may produce more. | Around 17% average weight loss in trials |
| Convenience | Weekly dosing, requires injection | No needles; taken by mouth |
| Onset & consistency | Highly reliable absorption | Absorption can be more variable |
| Side-effect profile | Similar GLP-1 effects (nausea, GI symptoms) | Similar GLP-1 effects |
Further reading: Wegovy tablets vs injections
Yes, you can switch from Wegovy injections to Wegovy tablets if your prescriber confirms it is suitable. Current prescribing guidance supports switching from Wegovy 2.4mg once-weekly injection to Wegovy 25mg once-daily tablets, starting the tablet 7 days after the last injection. Lower injection doses do not have the same guidance and will be at the discretion of your prescriber.
| Current Wegovy injection stage | Wegovy injection (weekly) | Wegovy tablet (daily) |
|---|---|---|
| Starting dose | 0.25mg | 1.5mg |
| Step 2 | 0.5mg | 1.5mg |
| Step 3 | 1mg | 4mg |
| Step 4 | 1.7mg | 9mg |
| Maintenance dose | 2.4mg | 25mg |
| Higher-dose injection | 7.2mg | 25mg |
Further reading: Switching from Wegovy injections to tablets
The lower-dose switching suggestions in this table are approximate and based on clinical judgement, not official dose equivalence.
The price of Wegovy tablets will start at £98.99.
Wegovy tablets have now been approved by the MHRA, but they are not currently available to buy while UK stock is awaited.
Stock is expected to take a few weeks to arrive, although an exact availability date has not yet been confirmed.
Join our waitlist to be among the first to know when Wegovy tablets are available to buy online.
Wegovy tablets should be taken once a day, first thing in the morning, on an empty stomach. Take the tablet with a small amount of plain water only, then wait at least 30 minutes before eating, drinking, or taking any other oral medicines.
The tablet must be swallowed whole. Do not split, crush, chew or dissolve it, as this may affect how the medicine is absorbed.
| Step | What to do |
|---|---|
| 1 | Take Wegovy tablets once daily in the morning. |
| 2 | Take the tablet on an empty stomach. |
| 3 | Swallow the tablet whole with plain water only. |
| 4 | Do not take it with tea, coffee, juice, milk, fizzy drinks or any other liquid. |
| 5 | Wait at least 30 minutes before eating, drinking or taking other oral medicines. |
| 6 | Take it the same way every day to help the medicine absorb properly. |
Further reading: How to take Wegovy tablets
| Treatment Phase | Time Period | Dose | Schedule |
|---|---|---|---|
| Starter Dose | Month 1 | 1.5mg | Once daily |
| Titration 1 | Month 2 | 4mg | Once daily |
| Titration 2 | Month 3 | 9mg | Once daily |
| Maintenance | Month 4 onwards | 25mg | Once daily |

Source: Wegovy® Pill Guide and Dosing Information | Wegovy® (semaglutide)
Further reading: Wegovy tablets dosage
The most common side effects are digestive symptoms, particularly when starting treatment or increasing the dose. Very common side effects affect at least 1 in 10 people. Common side effects affect between 1 in 100 and 1 in 10 people.
| Frequency | Side effect | How to manage symptoms |
|---|---|---|
| Very common | Nausea | Eat smaller meals, avoid greasy or rich foods, eat slowly, and stop eating when full. Symptoms often improve as your body adjusts. |
| Very common | Diarrhoea | Drink plenty of fluids to prevent dehydration. Avoid very fatty foods, alcohol and large meals. Seek advice if diarrhoea is severe or persistent. |
| Very common | Vomiting | Take small sips of water regularly. Avoid large meals and seek medical advice if vomiting continues or you cannot keep fluids down. |
| Very common | Constipation | Increase fluids, fibre and gentle movement. Consider speaking to a pharmacist about a suitable constipation remedy if needed. |
| Very common | Stomach pain or abdominal discomfort | Eat smaller portions and avoid heavy, spicy or high-fat meals. Seek urgent advice if pain is severe, persistent or spreads to the back. |
| Very common | Headache | Stay hydrated and eat regularly where possible. Speak to a pharmacist about suitable pain relief if needed. |
| Very common | Fatigue | Rest where needed, keep hydrated and avoid skipping meals completely. Symptoms may improve after the dose settles. |
| Common | Indigestion or dyspepsia | Eat smaller meals, avoid lying down soon after eating, and reduce spicy, acidic or fatty foods. |
| Common | Acid reflux or heartburn | Avoid late meals, large portions, alcohol and trigger foods. Raising the head of the bed may help night-time reflux. |
| Common | Bloating or abdominal distension | Eat slowly, avoid fizzy drinks, and reduce large or heavy meals. Gentle walking may help. |
| Common | Burping | Avoid carbonated drinks, chewing gum and eating too quickly. Smaller meals may reduce symptoms. |
| Common | Wind or flatulence | Reduce fizzy drinks and very large meals. Some people benefit from identifying and reducing trigger foods. |
| Common | Dizziness | Keep hydrated and avoid standing up too quickly. Seek advice if dizziness is persistent, severe or linked to fainting. |
| Common | Low blood sugar | Mainly relevant for people with type 2 diabetes using insulin or sulfonylureas. Monitor blood glucose and speak to your prescriber, as diabetes medicine may need adjusting. |
| Common | Gastroenteritis | Keep hydrated and rest. Seek medical advice if symptoms are severe, persistent, or there are signs of dehydration. |
| Common | Cold-like symptoms | Rest, fluids and simple pharmacy remedies may help. Seek advice if symptoms worsen or do not settle. |
| Common | Hair loss | This can occur during significant weight loss. Ensure adequate protein and micronutrient intake and seek advice if hair loss is severe or persistent. |
| Common | Gallstones | Seek medical advice if you develop upper right abdominal pain, fever, nausea, vomiting or yellowing of the skin or eyes. |
| Common | Increased heart rate | Seek medical advice if you notice a persistent racing heartbeat, palpitations, chest pain or shortness of breath. |
Seek urgent medical advice if you develop severe or persistent stomach pain, repeated vomiting, signs of dehydration, yellowing of the skin or eyes, swelling of the face or throat, difficulty breathing, a neck lump, trouble swallowing, or significant mood changes.
Further reading: Wegovy tablets side effects
Wegovy tablets are not suitable for:
Caution should be taken in people with:
Potential interactions are expected to mirror injectable semaglutide:
Although Wegovy tablets are now licensed for use in the UK, they cannot be prescribed or supplied until stock becomes available through UK supply channels. This is expected to take a few weeks.
Join our waitlist to be notified as soon as Wegovy tablets are available to order online.
No. You cannot currently buy Wegovy tablets online in the UK, even though they have now been approved by the MHRA. Stock is expected to take a few weeks to arrive, so Wegovy tablets are not yet available to order.
Once UK stock becomes available, Wegovy tablets should only be supplied by regulated pharmacies following an appropriate consultation and prescription approval.
Yes, they were approved by the MHRA on 11th June 2026.
Wegovy tablets have now been approved by the MHRA and are expected to become available in the UK soon. However, there is not yet a confirmed launch date, and stock is expected to take a few weeks to reach UK pharmacies.
Chemist Click will offer Wegovy tablets online once available, subject to stock availability, clinical suitability and prescription approval.
Join our Wegovy tablets waitlist today to be among the first to know when they are available to order.
Wegovy tablets will start at £98.99 from Chemist Click.
Yes. Wegovy tablets are a form of oral semaglutide.
Semaglutide is the active ingredient in Wegovy, and the tablet version is designed to be taken by mouth rather than injected. It works by mimicking the GLP-1 hormone, helping reduce appetite, increase fullness and support weight loss.
No. Wegovy tablets and Rybelsus both contain oral semaglutide, but they are not the same treatment.
Rybelsus is licensed for type 2 diabetes, not weight loss, and is available in lower doses.
Wegovy tablets are higher-dose oral semaglutide tablets developed specifically for weight management in countries where they are approved.
Wegovy tablets contain oral semaglutide, while orforglipron is a different oral GLP-1 tablet being developed by Eli Lilly.
Both are tablets designed to support weight loss, but they contain different active ingredients.
Wegovy tablets appear to offer weight loss results broadly comparable with standard Wegovy 2.4mg injections, although they have not been directly compared in a head-to-head UK trial.
In the OASIS 4 trial, Wegovy tablets produced average weight loss of 16.6% in people who stayed on treatment. However, higher-dose Wegovy injections may produce greater average weight loss in some patients.
In the OASIS 4 trial, people taking Wegovy tablets lost an average of 16.6% of their body weight when they stayed on treatment.
Around one in three people lost 20% or more of their body weight. Individual results can vary depending on dose, diet, activity levels, side effects, treatment adherence and starting weight.
Yes, Wegovy tablets are classified as prescription only medications.
They should only be supplied after a clinical consultation to check whether treatment is suitable and safe. You should not buy Wegovy tablets from unregulated websites, social media sellers or marketplaces.
You can join the Wegovy tablets waiting list by entering your details on the Chemist Click Wegovy tablets page.
We will let you know when Wegovy tablets become available in the UK. Treatment will only be supplied after a consultation has been assessed and approved by one of our pharmacists.
Superintendent Pharmacist
Written by Chemist Click
First created 7th May 2026
Last reviewed 13th June 2026